Panacea Life Sciences Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
Panacea Life Sciences Holdings, Inc. (PLSH) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 275.00 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2023-03-30
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2022-12-31 was 0.00 shares.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2022-09-30 was 0.00 shares.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2022-06-30 was 0.00 shares.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2022-03-31 was 275.00K shares.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2022 was 275.00K shares.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2020 was 50.00K shares, a 96.83% decline from fiscal 2019.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2019 was 1.58M shares, a 262.26% increase from fiscal 2018.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2018 was 435.75K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month |
|---|---|---|---|---|
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-30 | 0.00 shares derived: sum of 3 quarters · filed 2023-03-30 | 275.00K shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-14 | 275.00K shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 275.00K shares 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | 275.00K shares 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | 50.00K shares derived: sum of 2 quarters · filed 2021-04-23 | 50.00K shares derived: sum of 3 quarters · filed 2021-04-23 | 50.00K shares 10-K/A · filed 2021-04-23 |
| 2020-09-30 | 50.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-18 | 50.00K shares derived: sum of 2 quarters · filed 2020-11-18 | 50.00K shares 10-Q · filed 2020-11-18 | 909.80K shares derived: sum of 4 quarters · filed 2021-04-23 |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-19 | 0.00 shares 10-Q · filed 2020-08-19 | 859.80K shares derived: sum of 3 quarters · filed 2021-04-23 | 859.80K shares derived: sum of 4 quarters · filed 2021-04-23 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-06-29 | 859.80K shares derived: sum of 2 quarters · filed 2021-04-23 | 859.80K shares derived: sum of 3 quarters · filed 2021-04-23 | 859.80K shares derived: sum of 4 quarters · filed 2021-04-23 |
| 2019-12-31 | 859.80K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | 859.80K shares derived: sum of 2 quarters · filed 2021-04-23 | 859.80K shares derived: sum of 3 quarters · filed 2021-04-23 | 1.58M shares 10-K/A · filed 2021-04-23 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-14 | 718.75K shares 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 718.75K shares 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | 718.75K shares 10-Q · filed 2019-05-20 | |||
| 2018-12-31 | 435.75K shares 10-K · filed 2020-05-22 |